Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2006.080010v1, 2007; 10.1373/clinchem.2006.080010
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.080010v1
53/2/349    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kennerson, M. L.
Right arrow Articles by Nicholson, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kennerson, M. L.
Right arrow Articles by Nicholson, G. A.

Received on ,
Accepted on ,

Technical Briefs

Mutation Scanning the GJB1 Gene with High-Resolution Melting Analysis: Implications for Mutation Scanning of Genes for Charcot-Marie-Tooth Disease,

Marina L. Kennerson 1*, Trent Warburton 2, Eva Nelis 3, Megan Brewer 4, Patsie Polly 4, Peter De Jonghe 3, Vincent Timmerman 5, Garth A. Nicholson 6

1 Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord NSW, Australia 2139, and Molecular Medicine Laboratory, Concord Hospital, Concord NSW, Australia
2 John Morris Scientific, Victoria, Australia
3 Neurogenetics Group, Flanders Interuniversity Institute for Biotechnology, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium
4 Department of Pathology, School of Medical Sciences, University of New South Wales, Kensington, NSW, Australia
5 Peripheral Neuropathy Group, Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium
6 Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord NSW, Australia, and Molecular Medicine Laboratory, Concord Hospital, Concord NSW, Australia

* To whom correspondence should be addressed. E-mail: marinak{at}anzac.edu.au.

Background: X-linked Charcot-Marie-Tooth type 1 disease has been associated with 280 mutations in the GJB1 [gap junction protein, beta 1, 32kDa (connexin 32, Charcot-Marie-Tooth neuropathy, X-linked)] gene. High-resolution melting analysis with an automated instrument can be used to scan DNA for alterations, but its use in X-linked disorders has not been described.

Methods: A 96-well LightScanner for high resolution melting analysis was used to scan amplicons of the GJB1 gene. All mutations reported in this study had been confirmed previously by sequence analysis. DNA samples were amplified with the double-stranded DNA-binding dye LC Green Plus. Melting curves were analyzed as fluorescence difference plots. The shift and curve shapes of melting profiles were used to distinguish controls from patient samples.

Results: The method detected each of the 23 mutations used in this study. Eighteen known mutations provided validation of the high-resolution melting method and a further 5 mutations were identified in a blind study. Altered fluorescence difference curves for all the mutations were easily distinguished from the wild-type melting profile.

Conclusion: High-resolution melting analysis is a simple, sensitive, and cost-efficient alternative method to scan for gene mutations in the GJB1 gene. The technology has the potential to reduce sequencing burden and would be suitable for mutation screening of exons of large multiexon genes that have been discovered to be associated with Charcot Marie Tooth neuropathy.




The following articles in journals at HighWire Press have cited this article:


Home page
J Am Coll CardiolHome page
C. Chiu, R. D. Bagnall, J. Ingles, L. Yeates, M. Kennerson, J. A. Donald, M. Jormakka, J. M. Lind, and C. Semsarian
Mutations in Alpha-Actinin-2 Cause Hypertrophic Cardiomyopathy: A Genome-Wide Analysis
J. Am. Coll. Cardiol., March 16, 2010; 55(11): 1127 - 1135.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
E. Lyon and C. T. Wittwer
LightCycler Technology in Molecular Diagnostics
J. Mol. Diagn., March 1, 2009; 11(2): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
M. Pichler, M. Balic, E. Stadelmeyer, C. Ausch, M. Wild, C. Guelly, T. Bauernhofer, H. Samonigg, G. Hoefler, and N. Dandachi
Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors
J. Mol. Diagn., March 1, 2009; 11(2): 140 - 147.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Kennerson, G. Nicholson, B. Kowalski, K. Krajewski, D. El-Khechen, S. Feely, S. Chu, M. Shy, and J. Garbern
X-linked distal hereditary motor neuropathy maps to the DSMAX locus on chromosome Xq13.1-q21
Neurology, January 20, 2009; 72(3): 246 - 252.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. De Leeneer, I. Coene, B. Poppe, A. De Paepe, and K. Claes
Rapid and Sensitive Detection of BRCA1/2 Mutations in a Diagnostic Setting: Comparison of Two High-Resolution Melting Platforms
Clin. Chem., June 1, 2008; 54(6): 982 - 989.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. D. Laurie, M. P. Smith, and P. M. George
Detection of Factor VIII Gene Mutations by High-Resolution Melting Analysis
Clin. Chem., December 1, 2007; 53(12): 2211 - 2214.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. G. Vandersteen, P. Bayrak-Toydemir, R. A. Palais, and C. T. Wittwer
Identifying Common Genetic Variants by High-Resolution Melting
Clin. Chem., July 1, 2007; 53(7): 1191 - 1198.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Association for Clinical Chemistry.